Learning from the experts, one mini-symposium at a time Learning from the experts, one mini-symposium at a time By Karina Leal|2021-05-24T15:05:31+00:00May 24, 2021| Read More
Creating a Pipeline for Hypotheses Generation and Reagent Development in Alzheimer’s Creating a Pipeline for Hypotheses Generation and Reagent Development in Alzheimer’s By Karina Leal|2021-05-17T16:38:08+00:00May 17, 2021| Read More
Catalyzing Diversity in Alzheimer’s Disease Target Discovery Through Open Science Catalyzing Diversity in Alzheimer’s Disease Target Discovery Through Open Science By Karina Leal|2021-05-17T20:54:42+00:00May 17, 2021| Read More
NIH-funded translational research centers to speed, diversify Alzheimer’s drug discovery NIH-funded translational research centers to speed, diversify Alzheimer’s drug discovery By Karina Leal|2020-07-22T20:18:45+00:00July 7, 2020| Read More
National Institute on Aging awards $73 million for new Alzheimer’s drug discovery centers National Institute on Aging awards $73 million for new Alzheimer’s drug discovery centers By Karina Leal|2020-07-07T19:05:43+00:00October 1, 2019| Read More
Bringing Open Science to Drug Discovery for Alzheimer’s Bringing Open Science to Drug Discovery for Alzheimer’s By Karina Leal|2020-07-07T18:34:13+00:00October 1, 2019| Read More
IU School of Medicine awarded $36 million NIH grant for Alzheimer’s disease drug discovery center IU School of Medicine awarded $36 million NIH grant for Alzheimer’s disease drug discovery center By Karina Leal|2020-07-07T18:59:53+00:00October 1, 2019| Read More
